Home › Funds › J. Stern & Co. LLP › DXCM
J. Stern & Co. LLP position in DXCM
DEXCOM INC · Health Care
J. Stern & Co. LLP reported holding 28,314 shares of DXCM (DEXCOM INC) in its Q3 2026 13F filing — a position valued at US$2.4M, representing 0.25% of its reported portfolio and ranking #29 among its reported holdings. J. Stern & Co. LLP has disclosed DXCM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How J. Stern & Co. LLP's DXCM position evolved
J. Stern & Co. LLP first disclosed a stake in DXCM in Q4 2023 at 1,342 shares (US$163K). The position peaked in Q3 2025 at 72,332 shares, worth US$4.9M. Across 12 filings, J. Stern & Co. LLP increased the stake 9 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 28,314 shares valued at US$2.4M. Notable position changes include a 338% increase in Q2 2024 (shares fell 41% over the following quarter), a 115% increase in Q3 2024 (shares rose 17% over the following quarter), a 2115% increase in Q4 2025 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.34K | $162.85K | New |
| Q1 2024 | 2.49K | $344.95K | Add |
| Q2 2024 | 10.88K | $1.23M | Add |
| Q3 2024 | 23.44K | $1.57M | Add |
| Q4 2024 | 27.62K | $2.15M | Add |
| Q1 2025 | 37.68K | $2.57M | Add |
| Q2 2025 | 40.05K | $3.38M | Add |
| Q3 2025 | 72.33K | $4.87M | Add |
| Q4 2025 | 1.60M | $1.60M | Add |
| Q1 2026 | 26.66K | $1.67M | Reduce |
| Q2 2026 | 28.23K | $1.90M | Add |
| Q3 2026 | 28.31K | $2.44M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DXCM and 13F data
DXCM (DEXCOM INC) is a Health Care company. 31 other funds we track also report a position in DXCM — the largest reported positions include Baillie Gifford & Co (US$1.25B), Castle Hook Partners LP (US$260.7M), Employees Provident Fund Board (US$189.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DXCM
- Baillie Gifford & Co 14.52M sh · $1.25B · Q3 2026
- Castle Hook Partners LP 3.87M sh · $260.67M · Q2 2026
- Employees Provident Fund Board 2.19M sh · $188.98M · Q3 2026
More on J. Stern & Co. LLP
FAQ
How long has J. Stern & Co. LLP held DXCM?
J. Stern & Co. LLP has disclosed DXCM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is J. Stern & Co. LLP's current position in DXCM?
As of Q3 2026, J. Stern & Co. LLP holds 28.31K shares of DXCM (DEXCOM INC), valued at $2.44M, representing 0.25% of its reported portfolio and ranking #29.
Has J. Stern & Co. LLP been buying or selling DXCM?
In the latest 13F filing (Q3 2026), J. Stern & Co. LLP held unchanged its position in DXCM. The position peaked in Q3 2025 at 72.33K shares.
Which other funds hold DXCM?
Other major institutional holders of DXCM include Baillie Gifford & Co, Castle Hook Partners LP, Employees Provident Fund Board, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.